Primary Hyperparathyroidism and Associated Neoplasms by Kambouris, Angelos A. et al.
Henry Ford Hospital Medical Journal 
Volume 35 Number 4 Article 10 
12-1987 
Primary Hyperparathyroidism and Associated Neoplasms 
Angelos A. Kambouris 
Mohammed R. Ansari 
Gary B. Talpos 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Kambouris, Angelos A.; Ansari, Mohammed R.; and Talpos, Gary B. (1987) "Primary Hyperparathyroidism 
and Associated Neoplasms," Henry Ford Hospital Medical Journal : Vol. 35 : No. 4 , 207-210. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol35/iss4/10 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
primary Hyperparathyroidism and Associated Neoplasms 
An 
gelos A. Kambouris, MD,* Mohammed R. Ansari, MD,* and Gary B. Talpos, MD* 
F requent use of automated multichannel analyzers has con-tributed to the diagnosis of hypercalcemia in large numbers 
of patients, many of them completely asymptomatic. While pri-
mary hyperparathyroidism has been diagnosed in 0.1% to 0.3% 
ofthese patients, malignant neoplasms continue to be the most 
frequent cause of hypercalcemia (1,2). This is particulariy tme 
inpatients with known and previously treated cancers, where 
hypercalcemia is attributed to bone metastases or to humoral 
factors secreted by the neoplasms, downplaying the role of 
primary hyperparathyroidism as the underlying cause. Such 
assumptions may lead to inappropriate workup, to delay in diag-
nosis, and occasionally to treatment delay in patients with pre-
viously treated cancers that are known to have a poor prognosis. 
The repetitive encounter of patients with hypercalcemia, either 
en-oneously attributed to malignancy or whose parathyroid dis-
ease was left untreated because of previously treated cancers, 
prompted a review of our experience with parathyroidectomy 
over a four-year period and formulates the basis for this report. 
Materials and Methods 
The records of 111 patients who underwent parathyroidectomy 
between January 1, 1980, and December 31, 1983, were retro-
spectively reviewed. The series included 85 women (76.5%) 
and 26 men ranging in age from 25 to 91 years, with a median 
age of 57 years. Of the 111 patients, 84 were white and 27 were 
black. 
Operative reports, histopathological reports, and discharge 
summaries were carefully reviewed to ascertain primary diag-
nosis, associated tumors or tumorous conditions found at op-
eration, and extent of operative procedures performed. In all 
instances, information regarding existing or previously treated 
neoplasms was carefully sought, and the status of such malig-
nancies was recorded. In addition, information regarding pre-
vious operations in the head and neck area, and exposure to 
neck irradiation, was carefully extracted. Postoperative calcium 
levels were also reviewed to assess the effectiveness of para-
thyroidectomy in controlling hypercalcemia. 
Results 
Ten (9%) of the 111 patients underwent treatment for 13 \ m -
°"s invasive cancers prior to parathyroidectomy. Table 1 details 
histologic types and time of definitive treatment of those carci-
nomas as well as parathyroid histology on the excised glands. 
Significantiy, one patient had undergone successful treatment of 
sequential bilateral breast cancers and colon cancer, the last one 
16 years prior to parathyroidectomy; and another patient had 
undergone surgical treatment of cancer of the larynx and of the 
lung, the latter one three years prior to parathyroidectomy. In all 
instances, carcinoma had been successfully treated, and de-
tailed investigation failed to reveal metastases. Benign thyroid 
nodules were found and excised in two of these patients at para-
thyroidectomy. Hypercalcemia was corrected in all ten patients 
by removal of a single adenoma in seven patients and two or 
more hyperplastic glands in the remaining three patients. 
Nine patients (8.1%) were found to have concurrent malig-
nant neoplasms at parathyroidectomy (Table 2). One of these 
patients (case 1, Table 2), a 68-year-old white woman, had 
squamous cell carcinoma of the tongue with neck metastases. 
Primary hyperparathyroidism was diagnosed through orderly 
workup of her hypercalcemia. Removal of two hyperplastic 
parathyroids at the time of radical neck dissection corrected her 
hypercalcemia. Of the remaining eight patients, five had occult 
papillary thyroid carcinomas found and excised at parathy-
roidectomy. Four of these (cases 3-6, Table 2) were incidental 
findings in the histological examination of excised thyroid nod-
ules. The fifth patient (case 2, Table 2) was found to have an 11 
mm papillary thyroid cancer in a totally atrophic thyroid gland 
during removal of three parathyroid glands, only one of which 
was hyperplastic. Hypercalcemia persisted, and the patient was 
reoperated on two months later Reexploration of the neck and 
mediastinal exploration failed to locate the missing parathyroid. 
The patient was hypercalcemic two years later Another patient 
(case 9, Table 2), the only one with irradiation to the neck for 
hypertrophic tonsils 24 years previously, underwent total thy-
roidectomy and subtotal parathyroidectomy for concurrent 
papillary thyroid cancer and parathyroid hyperplasia. Hy-
percalcemia persisted but was corrected when additional 
hyperplastic parathyroid tissue was excised five months later 
The remaining two patients (cases 7 and 8, Table 2) had 
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Table 1 
Patient Previously Treated Treatment Parathyroid Treatment Additional Findings 
No. Age/Sex Carcinoma Year Diagnosis Year and Comments 
1 7 I/F Carcinoma left breast 
Carcinoma right breast 
Carcinoma right colon 
1962 
1966 
1966 
Adenoma 1982 Hysterectomy 1962 
F^otidectomy 1971 
2 55/F Carcinoma right breast 1979 Adenoma 1982 Multinodular goiter 
3 67/F Carcinoma of colon ? Adenoma 1983 
4 66/M Carcinoma of bladder 
(cystectomy, ileal loop) 
1967 Hyperplasia, 2 glands 1980 
5 57/F Papillary thyroid 
carcinoma 1979 Adenoma 1980 Hashimoto's thyroiditis 
6 76/F Carcinoma of rectosigmoid 
colon (low resection) 1967 Adenoma 1981 
7 58/M Carcinoma of stomach 1976 Adenoma 1981 
8 25/F Carcinoma of colon 1980 Adenoma 1981 Sarcoidosis 
9 58/F Carcinoma of larynx 
(laryngectomy); 1975 Nodular hyperplasia. 1981 
carcinoma of lung. 2 glands 
resected 1978 
10 43/F Renal adenocarcinoma 
(nephrectomy) 
1977 Hyperplasia, 
3 '/2 glands 
1980 
clinically recognized and appropriately treated papillary cancers 
at parathyroidectomy. Excluding the patient with oral cancer, as-
sociated nonmalignant thyroid nodules were excised in five of 
these eight patients and in fact led to the diagnosis of all thyroid 
cancers. 
Eight patients (7.2%) had nonneoplastic thyroid nodules 
of significance at parathyroidectomy (cases 1 and 2, Table 1, 
and cases 1-6, Table 2). Seven of the excised nodules were ofthe 
colloid variety, and one represented Hashimoto's thyroiditis. 
Parathyroidectomy was successful in seven patients, but misin-
terpretation of a colloid nodule at surgery accounted for the 
failure to identify parathyroid pathology in one patient. She was 
subsequently reoperated on elsewhere, and her hypercalcemia 
was corrected. Thus, nonneoplastic thyroid nodules alone (eight 
Table 2 
Hyperparathyroidism and Concurrent Carcinoma 
Patient 
No. Age/Sex 
68/F 
57/F 
54/F 
52/F 
66/F 
53/F 
61/F 
40/F 
33/F 
Parathyroid 
Diagnosis 
Treatment 
Year 
Concurrent 
Carcinoma 
Other Concurrent 
Tumors 
Hyperplasia. 
2 glands 
Hyperplasia 
Adenoma 
Hyperplasia 
Adenoma 
Adenoma 
Adenoma 
Adenoma 
Hyperplasia 
1982 
1982 
1982 
1983 
1980 
1980 
1981 
1981 
1982 
Squamous cell 
carcinoma of 
tongue, with 
neck metastases 
Papillary thyroid 
carcinoma 
Papillary thyroid 
carcinoma (11 mm) 
Papillary thyroid 
carcinoma (4 mm) 
Occult papillary 
thyroid 
carcinoma 
Sclerosing 
papillary thyroid 
carcinoma 
Papillary thyroid 
carcinoma 
Papillary thyroid 
carcinoma 
Papillary thyroid 
carcinoma 
Colloid nodular 
goiter 
Colloid nodules. 
Hashimoto's 
thyroiditis 
Attophic thyroid 
gland 
Multinodular 
goiter 
Multinodular 
goiter 
Colloid nodule 
Treatment and 
Comments 
Partial thyroidectomy; 
subtotal parathyroidectomy. 
Glossectomy and radical 
neck dissection, 1982. 
Total thyroidectomy and 
renioval of three 
parathyroid glands 
9/82. Mediastinal 
exploration and neck 
reexploration 11/82. 
Continues to have 
hypercalcemia, 1984. 
Total thyroidectomy, 
1982. Hysterectomy 
for leiomyoma of 
uterus, 1955. 
Partial thyroidectomy 
Partial thyroidectomy 
Partial thyroidectomy 
Subtotal thyroidectomy 
Subtotal thyroidectomy 
Tonsil irradiation 1959. 
Total thyroidectomy and 
subtotal parathyroidectomy 
10/82; persistent hyper-
calcemia. Additional remow 
of parathyroid tissue 3/83 
corrected hypercalcemia;— 
208 Henry Ford Hosp Med J—Vol 35, No 4, 1987 tYimary Hyperparathyroidism—Kanibouns 
""done hi 
Parathyroi. 
I l l r iH, . i_ . 
^^yPordHo, 
idings 
wts 
/ 1962 
y 1971 
goiter 
thyroiditis 
;s were ofthe 
i thyroiditis. 
;s, but misin-
mted for the 
ient. She was 
ypercalcemia 
s alone (eight 
t and 
nts 
;ctomy; 
.thyroidectomy. 
' and radical 
on, 1982. 
tomy and 
iree 
glands 
stinal 
ind neck 
a 11/82. 
) have 
lia, 1984. 
;tomy, 
:rectomy 
ma of 
i . 
ectomy 
ectomy 
ectomy 
lidectomy 
)idectomy 
ion 1959. 
idectomy and 
rathyroidectoiny 
iistent hyper- j 
.dditional removal 
oid tissue 3/83 
lypercalcejru^ 
sm—Kambouris 
Instances), with concurrent thyroid cancers (five instances), or 
in patients treated for carcinomas prior to parathyroidectomy 
/[vvo cases) were present in 15 (13.5%) of the 111 patients in this 
jgries (Table 3). 
Three patients had benign thyroid neoplasms resected at 
parathyroidectomy. Two of these were benign follicular ade-
nomas; the third was a benign Hurthle cell tumor Hashimoto's 
thyroiditis was also present in this last patient. In addition, a fol-
licular adenoma had been resected seven years before para-
thyroidectomy in one patient. Thus, concurrent or previously 
treated benign thyroid neoplasms were found in four patients in 
this series. 
Four additional patients were known to have multiple endo-
crine neoplasia (MEN) syndromes, and their neoplasms were 
not included in this analysis. In addition, three of the patients 
had undergone surgical treatment for benign neoplasms of re-
mote organs years prior to parathyroidectomy (parotid gland, 
ovaries, and utems). 
In summary, 38 (34.2%) of 111 patients had various tumors or 
tumorous conditions either previously treated or concurrently 
managed at the time of parathyroid resection. Ten (9%) had been 
successfully treated for invasive cancers. Nine (8.1%) had con-
current cancers, eight of them involving the thyroid gland, four 
had neoplasms related to MEN syndromes, and four had benign 
thyroid neoplasms. Nonneoplastic nodules, either alone or in 
conjunction with concurrent or previously treated cancers, were 
found in 15 (13.5%) of the patients. These findings and the de-
tails of the types of the previously treated carcinomas are sum-
marized in Table 3. 
Discussion 
The association of primary hyperparathyroidism with nodular 
thyroid disease and also with nonmedullary thyroid carcinoma 
has been extensively reported in the past 30 years. Comprehen-
sive reports by Prinz et al (3), Nishiyama et al (4), Linos et al (5), 
Granberg et al (6), and Hedman and Tisell (7) summarize avail-
able information. 
These reports emphasize that 1) nodular thyroid disease is 
found in 20% to 50% of patients undergoing parathyroidectomy; 
2) nonmedullary thyroid carcinoma of the occult as well as of 
the clinically significant variety occurs in 1.5% to 24.5% of the 
patients; 3) this association is more obvious in patients with 
prior exposure to neck irradiation, especially for papillary thy-
roid cancers; and 4) many patients with primary hyperpara-
thyroidism, when carefully questioned, will confirm irradia-
tion exposure at some remote point in the past. 
In our series, 15 patients (13.5%) had thyroid nodules of non-
neoplastic nature excised at parathyroidectomy, and another ten 
patients (9%), excluding the four MEN-related cancers, had 
nonmedullary thyroid cancers excised. Two additional patients 
had been previously treated for nonmedullary thyroid cancers, 
and one had a follicular adenoma resected seven years before 
parathyroidectomy. Thus, 25% of the patients in this series had 
nodular thyroid disease, the majority resected at parathyroid-
ectomy. This association may in fact be lower than its actual oc-
'•''rrence, since only significant thyroid nodules are likely to be 
Table 3 
Neoplasms and Ibmorous Conditions Documented in 111 
Patients Operated on for Hyperparathyroidism 
Types of Tumors No. of ftaients 
Previously treated carcinomas 
Nonthyroid carcinomas 12 
Thyroid carcinomas 1 
Concurrent nonthyroid carcinomas 
Concurrent thyroid carcinomas 
Benign thyroid adenoma 
Follicular adenoma 3 
Hurthle cell tumor 1 
MEN-related neoplasms 
Benign tumors, remote organs 
Benign thyroid nodules, biopsied or excised 
K) 
4 
3* 
Total .38 
^'^y Ford Hosp Med J—Vol 35, No 4, 1987 
*One patient with concurrent thyroid cancer had hysterectomy for leiomyoma of the 
uterus. 
removed, while small or insignificant nodular disease or thy-
roiditis may not be biopsied or resected. While the frequency of 
nodular thyroid disease in our patients falls in the range of that 
reported in the literature, only one patient in the entire group had 
been exposed to neck irradiation 24 years before undergoing 
total thyroidectomy for papillary thyroid cancer and parathy-
roidectomy for hyperplasia. Irradiation to the neck cannot be 
considered a causative factor in the development of nodular thy-
roid disease, nonmedullary thyroid cancers, or primary hyper-
parathyroidism in this series. Since Rao et al (8) reported in 
1980 a 17% incidence of childhood irradiation among 130 pa-
tients with hyperparathyroidism from our institution and a 5% 
prevalence of hyperparathyroidism in irradiated patients (30 
times that found in the general population), the issue of iiradia-
tion exposure needs to be further investigated. Failure of our pa-
tients to recall such information, or failure to obtain and record 
such infonnation, may account for the difference. 
The association of nonthyroid cancers and hyperpara-
thyroidism was emphasized by Katz et al (9) in a 1970 report of 
six patients with primary hyperparathyroidism and breast can-
cer Subsequent to that report, Kaplan et al (10) reported on an 
autopsy study of 200 cases; 42% of patients with parathyroid 
adenomas found at autopsy and 16% of those with surgically 
confirmed adenomas had malignancies of other organs. In 1973 
Fan- et al (11) reported that 34 of 100 patients undergoing treat-
ment for primary hyperparathyroidism at Memorial Hospital, 
NY, had other cancers, antecedent, concurrent, or subsequent 
to parathyroidectomy. In 1974 Samaan et al (12) reemphasized 
this association in reporting on 23 patients who underwent 
preoperative localization and surgical treatment of hyper-
parathyroidism. Ten of these 23 patients (43.4%) had other tu-
mors, nine of them carcinomas. Two of the nine carcinomas 
were in the thyroid, but seven were in other organs, including 
two intestinal carcinoids and one islet cell tumor of the pan-
creas. In our series ten patients (9%) had been treated for 13 dif-
ferent carcinomas prior to parathyroidectomy (Tables 1 and 3). 
All cancers were inactive at the time of workup of the hyper-
calcemia, and primary hyperparathyroidism was confirmed in 
all instances. Breast, colon, and urinary tract cancers were the 
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most frequent types, but the numbers are too small to be signifi-
cant. Diagnosis of primary hyperparathyroidism in these pa-
tients was established through an orderly process of mling out 
active cancers or bone metastases by multiple documentations 
or elevated semm calcium levels, elevated immunoreactive para-
thormone and nephrogenous cyclic AMP, and other appropriate 
studies. Such a diagnostic process, as emphasized by Pumell et 
al (2), Skrabanek et al (13), and Drezner and Lebovitz (14), facil-
itates the diagnosis of primary hyperparathyroidism and its 
differentiation from pseudohyperparathyroidism or from hyper-
calcemia of skeletal metastases. Despite the definitive exclusion 
of active cancers, parathyroidectomy was occasionally delayed 
for reasons difficult to pinpoint. Eventually, however, primary 
hyperparathyroidism was surgically conected in all ten patients 
with a history of previously treated cancer This experience un-
derscores the importance of appropriate workup of hyper-
calcemia in patients with a history of or concunent invasive car-
cinomas and de-emphasizes the theoretical fear of metastases in 
that particular subgroup of hypercalcemic patients. 
Conclusions 
In our review of 111 patients undergoing parathyroidectomy 
over a four-year period, 38 patients (34.2%) had associated or 
previously treated tumors and tumorous conditions of the thy-
roid or of other organs. Significantly, nine patients had con-
cunent carcinomas, eight of them of the thyroid gland, and ten 
patients had undergone successful treatment for 13 various 
carcinomas before parathyroidectomy. 
The frequent concunence of thyroid nodules and primary 
hyperparathyroidism mandates extremely careful assessment 
and appropriate management of all thyroid masses at para-
thyroidectomy. Hypercalcemia in patients with previously 
treated cancers should be independently evaluated, and primary 
hyperparathyroidism should be excluded. In absence of bone 
metastases, hypercalcemia due to parathormone-like activity is 
rare. Therefore, biochemical evaluation of such patients should 
include multiple calcium and phosphoms determinations, para-
thormone determinations, and nephrogenous cyclic AMP mea-
surements to facilitate diagnosis. If the diagnosis of primary 
hyperparathyroidism is established, timely parathyroidectomy 
should be considered depending on risk factors and other 
clinical parameters. 
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